title: Clinical effects of a novel topical composition on persistent redness observed in patients who had been successfully treated with topical or oral therapy for papulopustular rosacea.
abstract: Rosacea is a condition most commonly characterized by central facial erythema and pupulopustules. There are highly effective drugs, both oral and topical, for papulopustular disease. At the present time, consistently effective pharmacologic therapy for erythematotelangiectatic rosacea is lacking. Patients whose papulopustular disease has been adequately treated are often still bothered by central facial erythema for which there is no adequate treatment short of laser and light. We present a study utilizing a novel topical composition evaluated for its ability to reduce background erythema remaining after adequate care of papulopustular disease. Patient, investigator and photographic evidence of erythema reduction was seen in 24/25 patients in this 8-week study.
authors.forename: Hilary
authors.initials: H
authors.lastname: Baldwin
authors.forename: Diane
authors.initials: D
authors.lastname: Berson
authors.forename: Maria
authors.initials: M
authors.lastname: Vitale
authors.forename: Margarita
authors.initials: M
authors.lastname: Yatskayer
authors.forename: Nannan
authors.initials: N
authors.lastname: Chen
authors.forename: Christian
authors.initials: C
authors.lastname: Oresajo
mesh_terms: D000279:Administration, Cutaneous; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004890:Erythema / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D012393:Rosacea / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D003879:Dermatologic Agents